Baltimore, MD, United States of America

Sian Jones

USPTO Granted Patents = 13 

 

 

Average Co-Inventor Count = 10.8

ph-index = 5

Forward Citations = 75(Granted Patents)


Location History:

  • Baltimore, MD (US) (2014 - 2021)
  • Newbury Park, CA (US) (2019 - 2022)

Company Filing History:


Years Active: 2014-2022

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):

Title: Celebrating the Innovations of Inventor Sian Jones

Introduction

Sian Jones, an accomplished inventor based in Baltimore, MD, has made significant contributions to the field of medical research. With a remarkable portfolio of 11 patents, she has focused her efforts on understanding and diagnosing malignant gliomas, a type of brain tumor that affects thousands of individuals.

Latest Patents

One of Sian's latest patents involves genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma. This groundbreaking research revealed mutations in the R132 residue of isocitrate dehydrogenase 1 (IDH1) found in the majority of grade II and III astrocytomas and oligodendrogliomas, as well as in glioblastomas that originated from these lower grade lesions. Furthermore, tumors lacking mutations in IDH1 were often observed to have mutations at the analogous R172 residue of the closely related IDH2 gene. These findings provide crucial insights into the pathogenesis and diagnosis of malignant gliomas, paving the way for improved treatment protocols.

Career Highlights

Sian Jones has collaborated with prestigious institutions such as The Johns Hopkins University and Duke University throughout her career. Her groundbreaking research and dedication to scientific advancement have positioned her as a leader in her field, as evidenced by her impressive patent portfolio and influential studies.

Collaborations

In her research journey, Sian has had the privilege of working alongside renowned scientists like Bert Vogelstein and Kenneth W. Kinzler. These collaborations have not only enriched her work but also contributed to the collective understanding of genetic mutations associated with malignant gliomas.

Conclusion

Sian Jones is a trailblazer in the field of medical research, making notable advancements in the understanding of malignant gliomas through her innovative patents and collaborative efforts. Her work continues to influence the diagnosis and treatment of this challenging disease, providing hope to many affected by it.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…